Delivery Order SPE2DB22D1106-SPE2DB25FEGV8

Award Date 4/8/25
Potential Completion Date 4/9/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,225.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of NUCYNTA 50 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of April 16, 2025 and is a firm fixed-price agreement. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen...
This is a $1,225.04 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of NUCYNTA 50 MG TABLET 100S, a medication, with a period of performance through January 8, 2025. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The award, valued at $1,155.92, is for the delivery of NUCYNTA 50 MG TABLET 100S, a prescription medication. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 31,...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,428.48 firm fixed-price contract is for the delivery of NUCYNTA 50 MG Tablets. The contract has a completion date of November 3, 2022 and was awarded on November 2, 2022. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,702.32 firm-fixed-price delivery order is for the supply of NUCYNTA 75 MG tablets. The contract has an ultimate completion date of March 5, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,311.84, is for the supply of 100 units of the medication NUCYNTA 50 MG TABLET. The award has an ultimate completion date of June 21, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,700.75 firm fixed price delivery order is for the supply of NUCYNTA 100 MG TABLET 100S, a prescription pain medication. This award is a task order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, which enables the agency to efficiently procure a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,340.56 firm fixed-price delivery order is for the supply of NUCYNTA 100 MG TABLETs (NSN 4567132251) with a period of performance through February 4, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA 50 MG tablet prescription medication. The contract has a firm-fixed price of $1,155.92 and an ultimate completion date of September 4, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,321.19 firm fixed-price delivery order is for the supply of 100 tablets of NUCYNTA 50 MG, a pain medication. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEGV8
    Delivery Order

This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,225.04 firm fixed-price delivery order is for the supply of NUCYNTA 50 MG TABLET 100S, a prescription medication. The contract has an ultimate completion date of April 9, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 7/8/25, 2:37 PM